日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

Cediranib联合顺铂和培美曲塞治疗未接受过化疗的不可切除恶性胸膜间皮瘤患者的II期试验(SWOG S0905)

Tsao, Anne S; Miao, Jieling; Wistuba, Ignacio I; Vogelzang, Nicholas J; Heymach, John V; Fossella, Frank V; Lu, Charles; Velasco, Mario R; Box-Noriega, Brandy; Hueftle, James G; Gadgeel, Shirish; Redman, Mary W; Gandara, David R; Kelly, Karen